Greg Walden actually said...
Recent recalls issued for a class of drugs known as angiotensin II receptor blockers, or ARBs, have led to public concern about the country's sourcing of finished drug products.
Context
Highlighting public concern over drug recalls and sourcing issues.
10/29/2019